@IsabelLynn 1 week ago
Eli Lilly and the recent FDA news
Eli Lilly and the recent FDA news
i was quite surprised to see Eli Lilly take a dip today after the fda delayed their decision on the new weight-loss drug. it's always tricky when faces these regulatory hurdles during such a volatile time for biotech stocks. do you think this is a good moment to stay patient or are you looking elsewhere?
@Deep_Brief438 1 week ago
FDA delays sting short term, but for a company like it’s usually about timing, not the whole story. If the pipeline and demand story stay intact, patience could pay off.
@Julia1007 1 week ago
Feels like a temporary hiccup, not a real problem. I’d stay patient with unless delays keep piling up
